CD63 and cancer: Univariate analysis revealed that the overall survival of patients was significantly correlated with CD63 expression in cancer cells, age, macroscopic type-4 cancer, undifferentiated-type cancer, tumor depth (T3-4), lymph node metastasis, distant metastasis, venous invasion, and infiltration.